Table 4. Results from competing risk regression investigating association between quartiles of MAIT cells and incident hepatic decompensation.
Competing risk regression-decompensation | Number exposed | Number of events | SHR | 95%CI | aSHR | 95%CI |
---|---|---|---|---|---|---|
% MAIT cells/T-cells | 71 | 11 | 1.12 | 0.83–1.52 | 1.19 | 0.91–1.56 |
Age | 71 | 11 | 0.99 | 0.96–1.03 | 1.01 | 0.97–1.06 |
MELD-Na | 69 | 9 | 1.08 | 0.93–1.27 | 1.09 | 0.92–1.30 |
Quartile 1 | 18 | 3 | reference | reference | ||
% MAIT cells/T-cells | ||||||
Quartile 2 | 18 | 4 | 1.41 | 0.31–6.51 | 1.45 | 0.21–10.19 |
%MAIT cells/T-cells | ||||||
Quartile 3 | 19 | 2 | 0.57 | 0.10–3.24 | 0.60 | 0.09–4.03 |
% MAIT cells/T-cells | ||||||
Quartile 4 | 16 | 2 | 0.72 | 0.12–4.38 | 1.21 | 0.14–10.43 |
%MAIT cells/T-cells |
Abbreviations: MAIT cells mucosal-associated invariant T-cells, SHR subdistribution hazard ratio, aSHR adjusted subdistribution hazard ratio, CI confidence interval, MELD model of end-stage liver disease, Na sodium.